| Announce Date | 08/07/2025 |
| EPS Normalized Actual | $0.2435 (Miss by $-0.0014) |
| EPS GAAP Actual | $0.2435 (Miss by $-0.0014) |
| Revenue Actual | $2.74B |
| Revenue Surprise | Beat by $2740M |
| Announce Date | 12/30/2025 (Pre-Market) |
| EPS Normalized Estimate | $0.18307 |
| EPS GAAP Estimate | $0.18307 |
| Revenue Estimate | $7.28395477B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 0 | INF | 0 | 0 | 3 |
| Dec 2028 | 0.46274 | 20.44 | 0.45989 | 0.46518 | 3 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ1 2025 (Mar 2025) | 0.0892 | 0.0892 | 2.74B | -6.53% | 2740M |
| FQ2 2025 (Jun 2025) | 0.0892 | -0.07413 | 2.74B | -1.28% | -3667.65M |
| FQ4 2024 (Dec 2024) | 0.0251 | 0.0251 | 2.759B | -0.25% | 2759M |
| FQ3 2024 (Sep 2024) | 0 | 0 | 2.78B | -0.65% | 2780M |
| FQ2 2024 (Jun 2024) | 0.033 | 0.033 | 2.775B | 0.83% | 2775M |
| FQ1 2021 (Mar 2021) | 0.0252 | 0.0252 | 2.306B | 100% | 2306M |
| FQ2 2021 (Jun 2021) | 0.0278 | 0.0278 | 2.269B | 100% | 2269M |
| FQ1 2024 (Mar 2024) | 0.046 | 0.046 | 2.919B | 100% | 2919M |
FQ4 Announce Date
12/30/2025 (Pre-Market)
Consensus EPS Estimates
0.18307
Consensus Revenue Estimates
7.28395477B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2027 (Sep 2027) | 0.19716 | -- | 0.1962 | 0.19812 | 1 |
| FQ2 2027 (Jun 2027) | 0.19996 | -- | 0.19774 | 0.20208 | 1 |
| FQ1 2027 (Mar 2027) | 0.19739 | -- | 0.1952 | 0.19948 | 1 |
| FQ4 2026 (Dec 2026) | 0.17377 | -- | 0.17184 | 0.17561 | 1 |
| FQ3 2026 (Sep 2026) | 0.18346 | -- | 0.18142 | 0.1854 | 1 |
| FQ2 2026 (Jun 2026) | 0.18674 | 52.23 | 0.18467 | 0.18872 | 1 |
| FQ1 2026 (Mar 2026) | 0.18315 | 51.3 | 0.18315 | 0.18315 | 0 |
| FQ4 2025 (Dec 2025) | 0.18307 | 86.29 | 0.18307 | 0.18307 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2027 (Sep 2027) | 7.5B | -- | 7.47B | 7.53B | 1 |
| FQ2 2027 (Jun 2027) | 7.5B | -- | 7.43B | 7.56B | 1 |
| FQ1 2027 (Mar 2027) | 7.48B | -- | 7.41B | 7.54B | 1 |
| FQ4 2026 (Dec 2026) | 6.91B | -- | 6.85B | 6.97B | 1 |
| FQ3 2026 (Sep 2026) | 7.31B | -- | 7.24B | 7.36B | 1 |
| FQ2 2026 (Jun 2026) | 7.03B | 61.05 | 6.97B | 7.09B | 1 |
| FQ1 2026 (Mar 2026) | 7.22B | 62.07 | 7.22B | 7.22B | 0 |
| FQ4 2025 (Dec 2025) | 7.28B | 62.12 | 7.28B | 7.28B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
1
EPS # of in-lines
1
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ1 2025 (Mar 2025) | 0.0892 | 0.0892 | 100% | |
| FQ2 2025 (Jun 2025) | 0.16333 | 0.0892 | -0.07413 | -83.11% |
| FQ4 2024 (Dec 2024) | 0.0251 | 0.0251 | 100% | |
| FQ3 2024 (Sep 2024) | 0 | 0 | NAN% | |
| FQ2 2024 (Jun 2024) | 0.033 | 0.033 | 100% | |
| FQ1 2021 (Mar 2021) | 0.0252 | 0.0252 | 100% | |
| FQ2 2021 (Jun 2021) | 0.0278 | 0.0278 | 100% | |
| FQ1 2024 (Mar 2024) | 0.046 | 0.046 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ1 2025 (Mar 2025) | $0B | $2.74B | $2740M | 100% |
| FQ2 2025 (Jun 2025) | $6.41B | $2.74B | $-3667.65M | -133.86% |
| FQ4 2024 (Dec 2024) | $0B | $2.76B | $2759M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $2.78B | $2780M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $2.78B | $2775M | 100% |
| FQ1 2021 (Mar 2021) | $0B | $2.31B | $2306M | 100% |
| FQ2 2021 (Jun 2021) | $0B | $2.27B | $2269M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $2.92B | $2919M | 100% |